Table of contents
Volume 86, Issue 11
Published online 7 June 2002 (1667-1836)
Review |
Clinical |
Epidemiology |
Molecular and Cellular Pathology |
Experimental Therapeutics
Editorial
Why hasn't the National Institute been 'NICE' to patients with colorectal cancer? FREE
M P Saunders and J W Valle
Br J Cancer 86: 1667-1669; doi:10.1038/sj.bjc.6600369
Review
Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer? FREE
C J Twelves and J Cassidy
Br J Cancer 86: 1670-1676; doi:10.1038/sj.bjc.6600341
Clinical
Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer FREE
D Cunningham, S Falk and D Jackson
Br J Cancer 86: 1677-1683; doi:10.1038/sj.bjc.6600204
Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer FREE
J P Hale, D R Cohen, T S Maughan and R J Stephens
Br J Cancer 86: 1684-1690; doi:10.1038/sj.bjc.6600273
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer FREE
A Huang, D Fuchs, B Widner, C Glover, D C Henderson and T G Allen-Mersh
Br J Cancer 86: 1691-1696; doi:10.1038/sj.bjc.6600336
Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients FREE
T Nousiainen, E Jantunen, E Vanninen and J Hartikainen
Br J Cancer 86: 1697-1700; doi:10.1038/sj.bjc.6600346
A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer FREE
T Seto, K Yoh, H Asoh, H Yamamoto, H Semba and Y Ichinose
Br J Cancer 86: 1701-1704; doi:10.1038/sj.bjc.6600337
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF FREE
M Colleoni, H J Litman, M Castiglione-Gertsch, W Sauerbrei, R D Gelber, M Bonetti, A S Coates, M Schumacher, G Bastert, C-M Rudenstam, C Schmoor, J Lindtner, J Collins, B Thürlimann, S B Holmberg, D Crivellari, C Beyerle, R L A Neumann and A Goldhirsch for the International Breast Cancer Study Group and the German Breast Cancer Study Group
Br J Cancer 86: 1705-1714; doi:10.1038/sj.bjc.6600334
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone FREE
J M O'Sullivan, V R McCready, G Flux, A R Norman, F M Buffa, S Chittenden, M Guy, K Pomeroy, G Cook, J Gadd, J Treleaven, A Al-Deen, A Horwich, R A Huddart and D P Dearnaley
Br J Cancer 86: 1715-1720; doi:10.1038/sj.bjc.6600348
Epidemiology
The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 1: radon gas FREE
UK Childhood Cancer Study Investigators
Br J Cancer 86: 1721-1726; doi:10.1038/sj.bjc.6600276
The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 2: gamma radiation FREE
UK Childhood Cancer Study Investigators
Br J Cancer 86: 1727-1731; doi:10.1038/sj.bjc.6600277
Cancer risks in populations living near landfill sites in Great Britain FREE
L Jarup, D Briggs, C de Hoogh, S Morris, C Hurt, A Lewin, I Maitland, S Richardson, J Wakefield and P Elliott
Br J Cancer 86: 1732-1736; doi:10.1038/sj.bjc.6600311
Cancer risks among long-standing spouses FREE
K Hemminki and Y Jiang
Br J Cancer 86: 1737-1740; doi:10.1038/sj.bjc.6600302
A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey FREE
V Costarelli, T J Key, P N Appleby, D S Allen, I S Fentiman and T A B Sanders
Br J Cancer 86: 1741-1744; doi:10.1038/sj.bjc.6600340
Benign thyroid disease and dietary factors in thyroid cancer: a case–control study in Kuwait FREE
A Memon, A Varghese and A Suresh
Br J Cancer 86: 1745-1750; doi:10.1038/sj.bjc.6600303
Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans FREE
R Pacella-Norman, M I Urban, F Sitas, H Carrara, R Sur, M Hale, P Ruff, M Patel, R Newton, D Bull and V Beral
Br J Cancer 86: 1751-1756; doi:10.1038/sj.bjc.6600338
Molecular and Cellular Pathology
Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers FREE
M Takimoto, G Wei, H Dosaka-Akita, P Mao, S Kondo, N Sakuragi, I Chiba, T Miura, N Itoh, T Sasao, R C Koya, T Tsukamoto, S Fujimoto, H Katoh and N Kuzumaki
Br J Cancer 86: 1757-1762; doi:10.1038/sj.bjc.6600328
Prognostic impact of chromosomal aberrations in Ewing tumours FREE
C M Hattinger, U Pötschger, M Tarkkanen, J Squire, M Zielenska, S Kiuru-Kuhlefelt, L Kager, P Thorner, S Knuutila, F K Niggli, P F Ambros, H Gadner and D R Betts
Br J Cancer 86: 1763-1769; doi:10.1038/sj.bjc.6600332
Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma FREE
I Pazgal, Y Zimra, C Tzabar, E Okon, E Rabizadeh, M Shaklai and O Bairey
Br J Cancer 86: 1770-1775; doi:10.1038/sj.bjc.6600330
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL FREE
G Cutrona, P Tasso, M Dono, S Roncella, M Ulivi, E M Carpaneto, V Fontana, M Comis, F Morabito, M Spinelli, E Frascella, L C Boffa, G Basso, V Pistoia and M Ferrarini
Br J Cancer 86: 1776-1785; doi:10.1038/sj.bjc.6600329
A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers FREE
C McIlhenny, W D George and J C Doughty
Br J Cancer 86: 1786-1789; doi:10.1038/sj.bjc.6600322
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance FREE
L-Y Luo, E P Diamandis, M P Look, A P Soosaipillai and J A Foekens
Br J Cancer 86: 1790-1796; doi:10.1038/sj.bjc.6600323
Heterogeneity of O 6-alkylguanine DNA-alkyltransferase expression in human breast tumours FREE
M J Clemons, M C Bibby, H El Teraifi, G Forster, J Kelly, S Banerjee, B Cadman, W D J Ryder, A Howell and G P Margison
Br J Cancer 86: 1797-1802; doi:10.1038/sj.bjc.6600324
Experimental Therapeutics
Periodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung FREE
K Ono, M Ishihara, K Ishikawa, Y Ozeki, H Deguchi, M Sato, H Hashimoto, Y Saito, H Yura, A Kurita and T Maehara
Br J Cancer 86: 1803-1812; doi:10.1038/sj.bjc.6600307
Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model FREE
N J Brown, C A Staton, G R Rodgers, K P Corke, J C E Underwood and C E Lewis
Br J Cancer 86: 1813-1816; doi:10.1038/sj.bjc.6600320
DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers FREE
A Satoh, M Toyota, F Itoh, T Kikuchi, T Obata, Y Sasaki, H Suzuki, A Yawata, M Kusano, M Fujita, M Hosokawa, K Yanagihara, T Tokino and K Imai
Br J Cancer 86: 1817-1823; doi:10.1038/sj.bjc.6600319
Serological identification and expression analysis of gastric cancer-associated genes FREE
A Lin
, A Stengrvics, Z Slucka, G Li, E Jankevics and R C Rees
Br J Cancer 86: 1824-1830; doi:10.1038/sj.bjc.6600321
Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis FREE
B M Fenton, S F Paoni, B K Beauchamp and I Ding
Br J Cancer 86: 1831-1836; doi:10.1038/sj.bjc.6600343
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
